Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 6.37% is 499% above its 5-year average of -1.59%, near the high end of its 5-year range (-74.63%–23.12%).
58.53% above its 12-month average of 4.02%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2026 (2026-06-30): 14.87%.
EBITDA MARGIN
6.37%
EBITDA MARGIN AVG TTM
4.02%
EBITDA MARGIN AVG 3Y
-2.75%
EBITDA MARGIN AVG 5Y
-1.59%
EBITDA MARGIN AVG 10Y
1.90%
EBITDA MARGIN AVG 15Y
3.92%
EBITDA MARGIN AVG 20Y
4.71%
CURRENT VS TTM AVG
+58.53%
CURRENT VS 3Y AVG
+331.51%
CURRENT VS 5Y AVG
+499.43%
CURRENT VS 10Y AVG
+234.42%
CURRENT VS 15Y AVG
+62.46%
CURRENT VS 20Y AVG
+35.14%
Lifecore Biomedical, Inc.
Market Cap
$241.94M
EBITDA Margin
6.37%
TTM Avg
4.02%
3Y Avg
-2.75%
5Y Avg
-1.59%
Market Cap
$242.28M
EBITDA Margin
32.18%
TTM Avg
32.18%
3Y Avg
-276.01%
5Y Avg
-1681.16%
Market Cap
$243.55M
EBITDA Margin
-1.78%
TTM Avg
-948.17%
3Y Avg
-2570.36%
5Y Avg
-2570.36%
Market Cap
$244.03M
EBITDA Margin
-38.32%
TTM Avg
-70.22%
3Y Avg
-602.02%
5Y Avg
-454.95%
Market Cap
$237.16M
EBITDA Margin
-100.05%
TTM Avg
-392.29%
3Y Avg
-392.29%
5Y Avg
-392.29%
Market Cap
$244.74M
EBITDA Margin
-1441.45%
TTM Avg
-4661.83%
3Y Avg
-5918.79%
5Y Avg
-3944.51%
Market Cap
$238.16M
EBITDA Margin
10.49%
TTM Avg
1.20%
3Y Avg
-4.19%
5Y Avg
-40.04%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $241.94M | 6.37% | 4.02% | -2.75% | -1.59% |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 32.18% | 32.18% | -276.01% | -1681.16% |
| Century Therapeutics, Inc. (IPSC)vs › | $243.55M | -1.78% | -948.17% | -2570.36% | -2570.36% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $244.03M | -38.32% | -70.22% | -602.02% | -454.95% |
| Invivyd, Inc. (IVVD)vs › | $237.16M | -100.05% | -392.29% | -392.29% | -392.29% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $244.74M | -1441.45% | -4661.83% | -5918.79% | -3944.51% |
| High Tide Inc. (HITI)vs › | $238.57M | 1.66% | 3.74% | -1.53% | 0.81% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $238.16M | 10.49% | 1.20% | -4.19% | -40.04% |
| Galectin Therapeutics Inc. (GALT)vs › | $246.22M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.18M | 25.65% | 38.25% | 43.91% | 51.79% |
Gross Margin
N/A
EBITDA Margin
6.4%
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 14.87% |
| 2026-06-30 | 14.87% |
| 2026-03-31 | -10.18% |
| 2025-09-30 | -3.49% |
| 2025-05-25 | 19.87% |
| 2025-02-23 | -19.78% |
| 2024-11-24 | 0.26% |
| 2024-08-25 | -38.82% |
| 2024-05-26 | 11.62% |
| 2024-02-25 | 3.11% |
| 2023-11-26 | 0.94% |
| 2023-08-27 | -26.29% |
| 2023-05-28 | 6.50% |
| 2023-02-26 | -12.50% |
| 2022-11-27 | -11.03% |
| 2022-08-28 | 4.55% |
| 2022-05-29 | -74.63% |
| 2022-02-28 | -13.47% |
| 2021-11-30 | 23.12% |
| 2021-08-31 | 5.55% |
| 2021-05-31 | 4.50% |
| 2021-02-28 | 16.61% |
| 2020-11-30 | 2.49% |
| 2020-08-31 | -5.43% |
| 2020-05-31 | -5.17% |
| 2020-02-29 | -6.70% |
| 2019-11-30 | -1.06% |
| 2019-08-31 | 0.09% |
| 2019-05-31 | 4.72% |
| 2019-02-28 | 4.29% |
| 2018-11-30 | 2.17% |
| 2018-08-31 | 2.16% |
| 2018-05-31 | 8.09% |
| 2018-02-28 | 4.25% |
| 2017-11-30 | 1.78% |
| 2017-08-31 | 4.44% |
| 2017-05-31 | 4.15% |
| 2017-02-28 | 5.16% |
| 2016-11-30 | 4.29% |
| 2016-08-31 | 6.06% |
| 2016-05-31 | 7.39% |
| 2016-02-29 | -24.21% |
| 2015-11-30 | 3.51% |
| 2015-08-31 | 4.54% |
| 2015-05-31 | 6.04% |
| 2015-02-28 | 4.81% |
| 2014-11-30 | 4.31% |
| 2014-08-31 | 3.78% |
| 2014-05-31 | 5.83% |
| 2014-02-28 | 8.95% |
| 2013-11-30 | 4.27% |
| 2013-08-31 | 3.49% |
| 2013-05-31 | 5.49% |
| 2013-02-28 | 7.23% |
| 2012-11-30 | 11.25% |
| 2012-08-31 | 4.76% |
| 2012-05-31 | 6.01% |
| 2012-02-29 | 6.77% |
| 2011-11-30 | 6.84% |
| 2011-08-31 | 5.77% |
| 2011-05-31 | -2.60% |
| 2011-02-28 | 6.87% |
| 2010-11-30 | 6.87% |
| 2010-08-31 | 8.07% |
| 2010-05-31 | 7.36% |
| 2010-02-28 | 6.18% |
| 2009-11-30 | 5.04% |
| 2009-08-31 | 6.77% |
| 2009-05-31 | 7.65% |
| 2009-02-28 | 6.17% |
| 2008-11-30 | 5.27% |
| 2008-08-31 | 7.46% |
| 2008-05-31 | 6.19% |
| 2008-02-29 | 9.94% |
| 2007-11-30 | 7.77% |
| 2007-08-31 | 6.90% |
| 2007-05-31 | 9.35% |
| 2007-02-28 | 51.09% |
| 2006-11-30 | 1.86% |
| 2006-08-31 | 1.48% |
| 2006-05-31 | 10.67% |
| 2006-02-28 | 7.56% |
| 2005-11-30 | -0.23% |
| 2005-08-31 | 0.83% |
| 2005-05-31 | 9.61% |
| 2005-02-28 | 6.70% |
| 2004-11-30 | 0.45% |
| 2004-08-31 | 0.86% |
| 2004-05-31 | 9.66% |
| 2004-02-29 | 3.85% |
| 2003-11-30 | -0.74% |
| 2003-08-31 | 1.35% |
| 2003-04-30 | 10.18% |
| 2003-01-31 | -2.41% |
| 2002-10-31 | 0.04% |
| 2002-07-31 | 0.69% |
